Journal
CURRENT OPINION IN BIOMEDICAL ENGINEERING
Volume 13, Issue -, Pages 9-15Publisher
ELSEVIER
DOI: 10.1016/j.cobme.2019.08.005
Keywords
Cell-free; Biosensors; TXTL; Point-of-care; Diagnostics
Categories
Funding
- ERC starting grant COMPUCELL
- INSERM Atip-Avenir program
- Bettencourt-Schueller Foundation
- French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]
Ask authors/readers for more resources
Recent years have witnessed a rapid increase of the use of cell-free systems for biosensor engineering. Building on the past decade of synthetic biology research mostly performed in living cells, researchers have developed a variety of cell-free applications capable of detecting antibiotics, clinical biomarkers, or nucleic acid sequences from viral and bacterial pathogens. Cell-free systems allow for simple fine-tuning of circuit component stoichiometry and provide a nonliving alternative to whole-cell biosensors that could expedite their path through regulatory approval. In addition, many of these systems have been shown to exhibit increased stability upon lyophilization, potentially enabling point-of-care applications and use in low-resource settings where continuous cold-chain maintenance may be difficult. Here, we discuss the latest advances in cell-free biosensor research and highlight some key challenges to address for the field to bring its full potential.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available